Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume 27, Issue 1, Pages 151-162
Publisher
Informa Healthcare
Online
2010-12-17
DOI
10.1185/03007995.2010.537589
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
- (2010) Bernd Lange et al. ADVANCES IN THERAPY
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Chronic low back pain analgesic studies – A methodological minefield
- (2010) Andrew R. Moore et al. PAIN
- Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
- (2010) James E. Wild et al. Pain Practice
- Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
- (2009) Sibilia Quilici et al. BMC Neurology
- Enriched Enrollment Randomized Withdrawal Trial Designs of Analgesics
- (2009) Nathaniel Katz CLINICAL JOURNAL OF PAIN
- Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use
- (2009) John H. Peniston et al. CLINICAL THERAPEUTICS
- Two-stage enriched enrolment pain trials: A brief review of designs and opportunities for broader application
- (2009) Steve N. Quessy PAIN
- Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial
- (2008) Joseph C Arezzo et al. BMC Neurology
- Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses
- (2008) R. Freeman et al. DIABETES CARE
- Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain
- (2008) Henry J. McQuay et al. PAIN
- Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors
- (2008) Roland Staud et al. PAIN
- Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): A 6-month, double-blind, placebo-controlled trial with pregabalin
- (2008) Leslie J. Crofford et al. PAIN
- Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations
- (2007) Robert H. Dworkin et al. JOURNAL OF PAIN
- Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options
- (2007) Aristidis Veves et al. PAIN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now